WallStreetZenWallStreetZen

NASDAQ: COGT
Cogent Biosciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for COGT

Based on 4 analysts offering 12 month price targets for Cogent Biosciences Inc.
Min Forecast
$22.00+212.06%
Avg Forecast
$24.25+243.97%
Max Forecast
$27.00+282.98%

Should I buy or sell COGT stock?

Based on 4 analysts offering ratings for Cogent Biosciences Inc.
Strong Buy
Strong Buy
2 analysts 50%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their COGT stock forecasts and price targets.

COGT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-27
lockedlocked$00.00+00.00%2023-08-30
lockedlocked$00.00+00.00%2023-06-13
lockedlocked$00.00+00.00%2023-06-12

1 of 1

Forecast return on equity

Is COGT forecast to generate an efficient return?
Company
N/A
Industry
-0.65%
Market
30.3%

Forecast return on assets

Is COGT forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.13%

COGT revenue forecast

What is COGT's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$30.6M
Avg 2 year Forecast
$117.6M
Avg 3 year Forecast
$361.8M

COGT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
COGT$7.05$24.25+243.97%Strong Buy
ZYME$8.73$8.00-8.36%Hold
RVNC$7.06$25.89+266.70%Strong Buy
BCYC$13.87$47.86+245.04%Strong Buy
CABA$13.69$32.71+138.96%Strong Buy

Cogent Biosciences Stock Forecast FAQ

Is Cogent Biosciences Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: COGT) stock is to Strong Buy COGT stock.

Out of 4 analysts, 2 (50%) are recommending COGT as a Strong Buy, 2 (50%) are recommending COGT as a Buy, 0 (0%) are recommending COGT as a Hold, 0 (0%) are recommending COGT as a Sell, and 0 (0%) are recommending COGT as a Strong Sell.

If you're new to stock investing, here's how to buy Cogent Biosciences stock.

What is COGT's revenue growth forecast for 2025-2027?

(NASDAQ: COGT) Cogent Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.56%.

Cogent Biosciences's revenue in 2023 is $0.On average, 2 Wall Street analysts forecast COGT's revenue for 2025 to be $2,631,095,807, with the lowest COGT revenue forecast at $1,278,083,855, and the highest COGT revenue forecast at $3,984,107,759. On average, 4 Wall Street analysts forecast COGT's revenue for 2026 to be $10,127,092,067, with the lowest COGT revenue forecast at $1,904,207,145, and the highest COGT revenue forecast at $16,133,655,565.

In 2027, COGT is forecast to generate $31,161,475,773 in revenue, with the lowest revenue forecast at $11,914,428,607 and the highest revenue forecast at $56,316,646,421.

What is COGT's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: COGT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.13%.

What is COGT's Price Target?

According to 4 Wall Street analysts that have issued a 1 year COGT price target, the average COGT price target is $24.25, with the highest COGT stock price forecast at $27.00 and the lowest COGT stock price forecast at $22.00.

On average, Wall Street analysts predict that Cogent Biosciences's share price could reach $24.25 by Nov 27, 2024. The average Cogent Biosciences stock price prediction forecasts a potential upside of 243.97% from the current COGT share price of $7.05.

What is COGT's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: COGT) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.